Factors associated with high‐dose antipsychotic prescriptions in outpatients with schizophrenia: An analysis of claims data from a Japanese prefecture

Abstract

Background Antipsychotics are commonly prescribed in high doses in combination with multiple psychotropic drugs. This study focused on the high‐dose antipsychotic prescriptions in patients with schizophrenia, while aiming to identify their associations with patients’ characteristics and concurrent psychotropic prescriptions. Methods This cross‐sectional study used claims data from a prefecture in Japan, between October 2014 and March 2015, to investigate antipsychotic prescriptions in adult outpatients with schizophrenia. The objective variable was the presence/absence of a high‐dose prescription. The explanatory variables included sex, age (category), presence of comorbid conditions, and the use of psychiatrist's therapy. Results After exclusion, a total of 13 471 patients with schizophrenia were analyzed. The frequency of high‐dose prescriptions was higher in men, with chlorpromazine‐equivalent values highest in the age ranges of 45‐54 and 35‐44 years for men and women, respectively. Patients aged below 65 years with cerebrovascular diseases showed a decrease in high‐dose prescriptions. There was a high frequency of polypharmacy psychotropic drug use in combination with a high‐dose antipsychotic prescription in patients aged below 65 years. Conclusion High‐dose antipsychotics are often used in combination with several psychotropic agents in patients with schizophrenia. Our findings emphasize the need to evaluate the prescribing behavior of physicians to avoid high‐dose antipsychotic prescriptions for improved patient care.

Cognitive impairment and C-reactive protein in clinically stable schizophrenia outpatients: a focus on sex differences

“…A possible explanation for this might be that men also showed a more severe psychopathological presentation, with higher positive symptoms, and thus required greater doses of antipsychotics than females. These results are in agreement with existing data, which found that high-dose prescription was more frequent in men 36 . Additional studies are needed to elucidate further the interaction between antipsychotic treatment, inflammation, and cognition, and should therefore consider the potential differences in the dose between sexes.…”

Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study

“…12 In Japan, prescribing behaviors that did not follow CPGs have been repeatedly reported in the treatment of schizophrenia and MDD. [13][14][15][16][17][18][19] Taken together, these results suggest that it is not easy for psychiatrists to prescribe according to the CPGs and that additional trials may be needed for the successful implementation of CPGs in clinical practice. Personal factors, such as lack of awareness and/ or familiarity with guidelines, have been determined to be a major factor in the barrier to CPG implementation.…”

Greater than the Sum: Applying Daily-Dose Equivalents to Antipsychotic Prescription Claims to Study Real-World Effects

“…Further, a 2015 report on the use of antipsychotics in older adults in Canada found differences in equivalent doses between patients residing in the community versus nursing homes and between those initiating typical versus atypical antipsychotics (Tadrous et al, 2015). Similar dose-conversion methods appear to have been employed in real-world studies in other jurisdictions to examine antipsychotic persistence (Iwata et al, 2020), doseinitiation (Takahashi et al, 2020), risk of death (Huybrechts et al, 2012b), and potential effect modification of adverse events (Huybrechts et al, 2012a). Q3) percentile values, respectively; middle line within each box represents the median (50th percentile value); dots represent outliers [values that are more than 1.5 times the interquartile range (IQR; Q3 -Q1) less than Q1 or more than 1.5*IQR greater than Q3], and whiskers extend to the smallest and largest values within this range.}…”